The Effect of Cognitive Exercise on Upper Extremity Functions, Balance and Cognitive Functions in Multiple Sclerosis
1 other identifier
interventional
32
1 country
1
Brief Summary
Multiple sclerosis (MS) is a chronic, progressive, demyelinating disease characterized by myelin sheath damage in the central nervous system that affects more than 2.5 million people worldwide and is more common in young adults aged 20-40 years, especially in women. Like physical impairments, cognitive impairments are a common clinical finding in individuals with MS, both in the early and late stages of the disease. Individuals with MS with cognitive impairment have more difficulty than those without cognitive impairment in participating in social and occupational activities, finding a job, working and performing routine household activities. It is also known that there is a high percentage of individuals with MS with upper extremity involvement in the early stages of the disease. Functional problems in the upper extremities lead to restriction of activity and participation in individuals with MS. Although it is stated that there is a high rate of upper extremity problems in individuals with MS, it is seen that they are not sufficiently understood and analyzed. When the literature is examined; evidence-based studies examining the effect of cognitive exercise on motor functions in MS in addition to physical exercises are quite limited. In this context, the subject of this study is to examine the effect of cognitive rehabilitation on upper extremity functions, balance and cognitive functions in individuals with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 13, 2024
CompletedFirst Submitted
Initial submission to the registry
July 16, 2024
CompletedFirst Posted
Study publicly available on registry
July 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2025
CompletedJuly 19, 2024
July 1, 2024
1 year
July 16, 2024
July 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive status
Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) was developed to assess basic cognitive abilities. It is a standardized method used between 6-70 years of age. This scale consists of 6 main sections and 26 subtests including orientation, visual perception, spatial perception, motor praxis, visual motor organization and thinking ability. It takes approximately 30-45 minutes to administer.
Change from baseline at 8 weeks treatment program after.
Upper extremity
Manual Ability Measure-36: The scale includes 23 items with a wide range of difficulty that measure the functional level of patients. Nine Hole Peg Test: Evaluates unilateral fine motor skills in the upper extremity. It requires the participants to first insert the nine sticks one by one into the nine holes and then remove them as quickly as possible against the clock. Box and Block Test: It is used to measure hand gross skill performance.The patient is asked to transfer the maximum number of blocks, one at a time, from one compartment of a wooden box divided into two compartments to the other within 60 seconds. Jebsen - Taylor Hand Function Test: It is an standardized test used to measure fine and gross motor functions of the hand by simulating daily life activities. It consists of 7 subtests: writing, simulated number spinning, lifting small objects, simulated feeding, stacking, moving large light and heavy objects.
Change from baseline at 8 weeks treatment program after.
Secondary Outcomes (4)
Coordination
Change from baseline at 8 weeks treatment program after.
Balance
Change from baseline at 8 weeks treatment program after.
Fatigue
Change from baseline at 8 weeks treatment program after.
Position Sense
Change from baseline at 8 weeks treatment program after.
Other Outcomes (2)
Disability Status
Change from baseline at 8 weeks treatment program after.
Cognitive Status
Change from baseline at 8 weeks treatment program after.
Study Arms (2)
Treatment group
EXPERIMENTALPatients in this group are the group in which a physiotherapy program consisting of cognitive rehabilitation and core-based upper extremity exercises will be applied.
Control group
ACTIVE COMPARATORPatients in this group are the group in which a physiotherapy program consisting of core-based upper extremity exercises will be applied.
Interventions
Cognitive rehabilitation is a treatment method used to regain or improve cognitive abilities.For the cognitive rehabilitation program, the Daily Exercise Package of the Norosoft Program, which mainly includes exercises to improve attention, information processing speed, verbal and visual memory functions, will be applied. Core-based Upper Extremity Exercises Breathing exercises, Core based stabilization and mobilization exercises Upper extremity exercises Coordination ve proprioception exercises
Breathing exercises, Core based stabilization and mobilization exercises Upper extremity exercises Coordination ve proprioception exercises
Eligibility Criteria
You may qualify if:
- Being between the ages of 18 and 65
- A definitive diagnosis of MS by a neurologist
- Having an Expanded Disability Status Scale (EDSS) score below 5.5
- No cognitive problems (Mini Mental Test score of 24 and above),
- Graduated from at least primary school
- No change in medical treatment in the last 6 months,
- Not having had an attack in the last 3 months and not using pulse steroid therapy
- Volunteering.
You may not qualify if:
- Having hearing and vision problems that prevent communication
- Having a neurological or psychiatric disease other than MS that causes cognitive impairment
- Pregnancy
- Oncological diseases
- Having other vestibular and orthopedic diseases that may affect balance
- Continue with a different exercise therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Yıldırım Beyazıt University
Ankara, 06010, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emine İpek Halatcı, MSc
Ankara Yildirim Beyazıt University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- single (outcomes assessor) single (outcomes assessor) the evaulation of the patients will be carried out by a blinded investigator.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2024
First Posted
July 19, 2024
Study Start
May 13, 2024
Primary Completion
May 15, 2025
Study Completion
June 15, 2025
Last Updated
July 19, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
Indivudual participant data will be available to the responsible researcher.